Anthony J. Dalby

Vorapaxar in the Secondary Prevention of Atherothrombotic Events

David A. Morrow, Eugene Braunwald, Marc P. Bonaca et al. · New England Journal of Medicine · 2012 · 941 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization

Matthew T. Roe, Paul W. Armstrong, Keith A.A. Fox et al. · New England Journal of Medicine · 2012 · 871 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

Stephen D. Wiviott, Eugene Braunwald, Dominick J. Angiolillo et al. · Circulation · 2008 · 757 citations

Medicine, Cardiology, Pharmacotherapy +17

Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease

Marc P. Bonaca, Deepak L. Bhatt, Robert F. Storey et al. · Journal of the American College of Cardiology · 2016 · 387 citations

Medicine, Cardiology, Pharmacotherapy +15

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15